Position in BHC
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$394,400
+$16,400 QoQ
Shares Held
80,000
+14.3% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
2.59%
of 13F equity value
Holder Rank
#91
of 220 holders
Holding Since
Mar 2020
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BHC Over Time
Shares Held
Position Value (USD)
Derivatives in BHC
reported options exposure · as of Jun 30, 2026CallValue
$1,725,500
CallShares
350,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Fore Capital, LLC holds $482,194 across 2 Drug Manufacturers - Specialty & Generic names. BHC ranks #1 (81.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BHC |
Bausch Health Companies Inc.
This page
|
80,000 | $394,400 | |
| 2 | EVO |
Evotec SE
|
31,355 | $87,794 |
All Filings in BHC
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,725,500 | 350,000 | Call | Sole | 2026-08-10 | |
| 2026-06-30 | $394,400 | 80,000 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $378,000 | 70,000 | Shares | Sole | 2026-05-08 | |
| 2026-03-31 | $2,160,000 | 400,000 | Call | Sole | 2026-05-08 | |
| 2025-12-31 | $834,000 | 120,000 | Shares | Sole | 2026-02-11 | |
| 2025-12-31 | $834,000 | 120,000 | Call | Sole | 2026-02-11 | |
| 2025-09-30 | $580,500 | 90,000 | Shares | Sole | 2025-11-13 | |
| 2020-03-31 | $155,000 | 10,000 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||